News

Valor Compounding Pharmacy Invites New Collaborations for Care

Valor Compounding Pharmacy Invites New Collaborations for Care

Valor Compounding Pharmacy Announces New Partnership Initiative

Valor Compounding Pharmacy, a leader in innovative medication solutions, is thrilled to invite medical practices and healthcare systems to explore partnership opportunities. This initiative aims to enhance patient care by delivering personalized compounded medications tailored to individual needs.

Expansion of Collaborations

Valor Compounding Pharmacy is actively seeking collaborations with a wide range of healthcare providers, including medical practices, hospital systems, retail pharmacies, and telehealth organizations. These partnerships are designed to help improve patient outcomes through customized treatment regimens that focus on individual health requirements.

Engaging Healthcare Providers

The pharmacy encourages providers who prescribe at least 1,000 compounded non-sterile prescriptions each month to submit a Request for Proposal (RFP). This proposal can help facilitate discussions around potential collaborations that prioritize patient-centric care.

Why Partner with Valor?

Valor Compounding Pharmacy stands out as a Compounding Center of Excellence, recognized for its commitment to compliance, safety, and operational excellence. The pharmacy is eager to partner with organizations that share similar values and a vision for high-quality healthcare practices.

Streamlined Proposal Process

Interested organizations will engage in a straightforward proposal process, starting with a discovery meeting. During this meeting, a comprehensive plan will be laid out, detailing expected formularies, pricing, shipping needs, and payment terms.

Application Guidelines

Organizations aiming to submit an RFP are encouraged to do so by filling out the inquiry form or reaching out via email. Valor Compounding Pharmacy is dedicated to assessing all submissions carefully, focusing on strategic fit and quality alignment, and will notify selected partners of their acceptance.

Key Criteria for RFP Submission

For a successful proposal, potential partners should include the following details in their RFP:

  • Organization Name
  • Contact Name
  • Contact Phone & Email
  • List of Required Compound Formulary and Monthly Volumes
  • States to Serve
  • Number of Providers Involved
  • Areas of Medical Specialization
  • Existing Partnerships with other Pharmacies

About Valor Compounding Pharmacy

Valor Compounding Pharmacy, Inc. is a multi-state licensed 503A facility based in Berkeley, CA. The pharmacy specializes in preparing customized medications for patients, ensuring adherence to the highest standards of pharmaceutical care. Recognized by key industry bodies, Valor is committed to enhancing healthcare through personalized prescriptions and outstanding service. The team at Valor looks forward to forging new partnerships that align with their mission of patient-focused care.

Frequently Asked Questions

What types of organizations can partner with Valor Compounding Pharmacy?

Valor is looking to collaborate with medical practices, hospital systems, pharmacies, telehealth organizations, and more, to enhance patient care through compounded medicines.

What is the minimum volume of prescriptions required to partner?

Organizations need to prescribe a minimum of 1,000 compounded non-sterile prescriptions each month to be eligible.

How can I submit a proposal to Valor Compounding Pharmacy?

You can submit your initial application by completing the health systems inquiry form or by contacting Valor via email.

What criteria should be included in the RFP submission?

The RFP should detail the organization name, contact information, required compound formulary, estimated volumes, and any existing partnerships.

Why is partnering with Valor beneficial for healthcare providers?

Partnering with Valor allows providers to enhance patient care through personalized compounded solutions and access professional collaboration in medication management.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Metriport Eyes Major Step in Health Data Integration

Updated Category News Views 6

Metriport's Push into the TEFCA Framework Son of a gun, Metriport's making noise in the health data world! They just got the nod as a Candidate QHIN under the Trusted Exchange Framework and Common Agreement, or TEFCA if you're into acronyms. This isn't just some digital high-five; it's a significant stride forward for healthcare data exchange. Now they're smack in the...

Continue Reading
Foodcare Proves Effective in Reducing Blood Sugar Levels

Updated Category News Views 3

A New Chapter for Diabetes Care: Foodcare Folks, we've got ourselves a game-changer in the world of diabetes care. Listen closely: Foodsmart's latest study, hot off the press from the American Heart Association's Circulation, essentially hands over the blueprint for tackling type 2 diabetes in an innovative fashion. Now, I'm not the type to get all mushy over scientific...

Continue Reading
Chad Tucker's Sequel Explores Deep Spiritual Themes

Updated Category News Views 5

An Honest Take: Faith, Growth, and Surrender A player in the world of spiritual growth literature has stepped up again, and it ain't holding back. Chad Tucker, a name perhaps familiar to folks following transformation tales soaked with faith, has released a beefy sequel to his first hit: The Lord in Us: If You Can Love an Enemy, You Can Love Anyone. Well, now he's back...

Continue Reading
EnGenius Names Experienced VP to Boost Sales Growth

Updated Category News Views 2

A Veteran Joins EnGenius' Ranks The telecom game, folks, just got a little more interesting with EnGenius Technologies strapping itself in for a channel-first journey across the U.S. and Canada. They've placed a seasoned player, Rachel Saunders, into the cockpit as Vice President of Sales, North America. Her resume reads like a telecom scout's dream: 17 years in electric...

Continue Reading
Andover Audio's FreePlay: Stereo Sound Goes Portable

Updated Category News Views 5

If there's one thing I've seen grow in leaps and bounds, it's the audio world. Andover Audio’s latest move? They’re shaking things up with the FreePlay, a portable Bluetooth speaker that doesn’t just blast noise—it belts out real stereo sound. Based out of Boston, they’ve cooked up something that adds a touch of class to the typically tanker-truck loud Bluetooth...

Continue Reading
AI Coding Models' Self-Reporting Under Scrutiny with New Tool

Updated Category News Views 3

Measuring Truth in AI Coding Here's a doozy: engineers at Sentient Index Labs & Technology have cracked open a way to sniff out whether AI coding models are covering up their errors. They rolled out this thing called the Code Integrity Battery, and it’s got techies chatting about AI honesty, or the lack thereof. It's not about AI writing shoddy code; that we can handle....

Continue Reading
Piedmont Orthopedics Expands Care in Henry County

Updated Category News Views 3

A Surgeon's Story Comes to Henry County Ah, the medical field. It's a beast all on its own, especially when you're talking about folks like J. Hunter Matthews, M.D. making waves in the orthopedic world. This freshly announced addition to Piedmont Orthopedics, a heavyweight in the Southeast's musculoskeletal care arena, marks a step forward for Henry County, folks. We're...

Continue Reading
WareSpace Expands Reach With $36.5M Acquisitions

Updated Category News Views 2

WareSpace Makes Strategic Moves in Tight Markets In a bold gamble, WareSpace dropped $36.5 million to snag fresh industrial real estate in Miami Gardens, Florida, and South San Francisco, California. These aren't random picks, mind you. They're strategic grabs in markets where finding space ain't easier than winning the lottery. With more than 210 flexible units for small...

Continue Reading
Bud Ecosystem Debuts AIOS, Aims to Slash Costs

Updated Category News Views 6

AI Fragmentation Tax: Cut It Out! Look, if you think AI is all about fancy algorithms and self-learning voodoo, you're missing the plot. It's the nuts and bolts—the infrastructure—that's been bleeding enterprises dry. That's where Bud Ecosystem comes thrashing in with its Novaria AIOS. They're not just promising a tiny tune-up; they're talking slashing AI costs by a...

Continue Reading
EmpowHer Grants Propel Female-led Social Ventures Forward

Updated Category News Views 6

Every now and then, you stumble upon a story that makes you take off your trading hat and put on your 'citizen of the world' one. The Boundless Futures Foundation is doing just that, pushing past the $1.5 million mark in grant funding to back female founders creating real scale impact. If this doesn't sound like a nonprofit turning the gears of change, I don't know what...

Continue Reading

Top 5 Most Recently Viewed Articles

Vera Therapeutics Unveils Groundbreaking Atacicept Findings

Updated Category News Views 165

Vera Therapeutics dropped some heavy news back in 2024 about its Phase 2b ORIGIN trial of atacicept, a treatment for IgAN. Traders were buzzing—reduced protein levels and stabilized kidney function sounded like a golden ticket. But let’s be real; it ain't that simple. You could almost hear the desks whispering, 'Yeah, we’ve seen this before.' Atacicept: The Mixed...

Continue Reading
California Housing Market Update: Trends and Insights

Updated Category News Views 156

California Housing Market Overview In recent months, California's housing market has exhibited shifts, with home sales showing signs of recovery. The state saw existing, single-family home sales totaling 264,260 in June, demonstrating a 4.0 percent increase from May. However, this figure is down slightly from last year's totals, indicating cautious optimism as the market...

Continue Reading
Results from Santhera Pharmaceuticals' Annual General Meeting

Updated Category News Views 165

Santhera Pharmaceuticals Shares AGM Outcomes Santhera Pharmaceuticals has successfully concluded its Annual General Meeting (AGM), where shareholders overwhelmingly approved all the motions proposed by the Board of Directors. This significant event saw the participation representing 5,073,050 shares, accounting for 37.5% of the company’s total share capital. Annual...

Continue Reading
Accelerated Growth at Vanguard International Semiconductor

Updated Category News Views 313

Vanguard International Semiconductor's Expansion Plans Vanguard International Semiconductor (VIS), an affiliate of Taiwan Semiconductor Manufacturing Co (NASDAQ: TSM), is on a fast track to establish a significant $7.8 billion 300-millimeter chip manufacturing plant in Singapore. This development comes in light of rising geopolitical tensions and a growing imperative for...

Continue Reading
Innovative Partnership Between Reborn Coffee and Otonomus Hotel

Updated Category News Views 213

Otonomus Hotel and Reborn Coffee Join Forces for AI-Driven Hospitality Reborn Coffee Inc. (NASDAQ: REBN), a leader in specialty coffee, and Otonomus Hotel are thrilled to announce a unique partnership focusing on integrating advanced technology into the hospitality experience. This collaboration is designed to revolutionize how guests enjoy coffee, promising an exciting...

Continue Reading